LifeScience

Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications

Reduces the cost of gene therapies by using 3-10x less sample than other methodsi while generating faster results and more drug substance informatio...

 August 03, 2023 | News

Gilead Launches Global All4Liver Grant Program Towards WHO's 2030 Viral Hepatitis Elimination Goal

  –  Themed ‘Test. Link. Prioritize’, the Grant Program will Target Projects Focusing on Viral Hepatitis Elimination by 2030 &...

 July 28, 2023 | News

BioMap unveils a “Life Science Leaderboard” to compare AI models

Highlights:  New AI leaderboard provides comparison of 25+ of the most important, representative and cutting-edge tasks across six distinct...

 July 26, 2023 | News

Biotheus Partners with BioNTech in Global Research Collaboration & License Deal

Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody and a clinical-stage...

 July 20, 2023 | News

Merck and Telix Continue Collaboration for Targeted Radiation Therapy Studies.

 Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Com...

 July 19, 2023 | News

Sartorius completes acquisition of Polyplus

Polyplus is a leading provider of innovative technologies for cell and gene therapies. Transfection reagents developed and produced by Polyplus are key com...

 July 18, 2023 | News

BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program

Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Ac...

 July 18, 2023 | News

Doer Biologics Announces License Agreement with BioNTech

Under the terms of the agreement, Doer Bio will grant BioNTech a worldwide license to utilize one of Doer Bio's innovative discoveries to research, develop...

 July 12, 2023 | News

Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All

With the inauguration of a new state-of-the-art cell therapy lab in early 2022, BeiGene is looking to broaden collaboration and expand ...

 July 12, 2023 | News

NK:IO Secures £1.6M Innovate UK Grant for Pioneering Cancer Therapy

  Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO’s platform, based on pionee...

 July 11, 2023 | News

3D bioprinting technology to be used for removing cancer cells

  □ A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for t...

 July 11, 2023 | News

Avantor Inaugurates Expanded Singapore Hub

- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technolo...

 July 11, 2023 | News

VitaDAO Launches VITA-FAST Tokens, Revolutionizing Governance in Longevity Research

The VITA-FAST tokens, which allow holders to make decisions on IP licensing, set experiment priorities, and govern research on autophagy, have been met wit...

 July 11, 2023 | News

Audax to Sell CorEvitas to Thermo Fisher Scientific

Based in Waltham, MA, CorEvitas is a provider of real-world evidence, leveraging proprietary data to help pharmaceutical customers uncover clinical insight...

 July 07, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close